ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Munafa ACAD (target) price & Options chain analysis (ACADIA Pharmaceuticals Inc.) Option chain analysis (ACAD) 18 Sun January Expiry

Munafa ACAD (target) price & Options chain analysis (ACADIA Pharmaceuticals Inc.) Option chain analysis (ACAD) 18 Sun January Expiry Which Call CE or PUT PE options to buy or sell in ACADIA Pharmaceuticals Inc. ACAD

0   ACAD Most Active Call Put Options

ACAD SPOT Price: 25.99 as on 16 Jan, 2026

ACADIA Pharmaceuticals Inc. (ACAD) target & price

ACAD Target Price
Target up: 27.06
Target up: 26.52
Target up: 26.35
Target up: 26.17
Target down: 25.63
Target down: 25.46
Target down: 25.28

Date Close Open High Low Volume
16 Fri Jan 202625.9926.7026.7025.811.36 M
15 Thu Jan 202626.5326.9927.0626.421 M
14 Wed Jan 202626.8626.5226.8726.350.95 M
13 Tue Jan 202626.4826.4527.0526.010.56 M
12 Mon Jan 202626.5926.5026.7425.901.05 M
09 Fri Jan 202626.7826.9427.2026.490.76 M
08 Thu Jan 202626.9127.3127.5026.551.3 M
07 Wed Jan 202627.4227.1227.7427.051.61 M
Munafa ACAD (target) price & Options chain analysis (ACADIA Pharmaceuticals Inc.) Option chain analysis (ACAD) 18 Sun January Expiry

ACAD Option Chain Data Analysis for ACADIA Pharmaceuticals Inc. ACAD option chain

Maximum Call writing has been for strikes:
Until yesterday Maximum Call writing has been for strikes:

Open Interest of Call writers for the options of ACADIA Pharmaceuticals Inc. ACAD is shifting downwards. This would mean that markets are slowly moving downwards, and buying CALLS and CE might not be profitable.

Maximum Put writing has been for strikes:
Until yesterday Maximum Put writing has been for strikes:

Open Interest of PUT writers for the options of ACADIA Pharmaceuticals Inc. ACAD is shifting downwards. This would mean that markets are slowly moving downwards, and buying PUTS and PE might be more profitable. However, above mentioned levels will serve as support so avoid buying PE below those above mentioned levels.

ACAD Option Chain Price Analysis for ACADIA Pharmaceuticals Inc. ACAD option chain

Stock is in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT ACADIA Pharmaceuticals Inc. ACAD at this time.

It appears as if ACADIA Pharmaceuticals Inc. ACAD gave a large move recently.

Stock of ACADIA Pharmaceuticals Inc. (ACAD) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, and the stock might move lower...

My analysis of ACADIA Pharmaceuticals Inc. is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if ACADIA Pharmaceuticals Inc. stays below 26.4, but if it comes above 26.4, then a intra day buy could be more profitable.
If you take a sell trade below 26.4, then use 26.4 as stoploss and 25.7 as target. However if you take a buy trade in ACADIA Pharmaceuticals Inc., then use 26.4 as stoploss and 26.94 as target.

ACADIA Pharmaceuticals Inc. ACAD Option Chain, OTM CE, ITM PE

Below is full option chain of ACADIA Pharmaceuticals Inc. for strikes which are OTM CALLS (CE), and ITM PUTS (PE).
These are CALLS which have only time value in them, no intrinsic value. PUTS however have both time value and intrinsic value in the premium.

ACADIA Pharmaceuticals Inc. ACAD Option Chain, ITM CE, OTM PE

Below is full option chain of ACADIA Pharmaceuticals Inc. for strikes which are ITM CALLS (CE), and OTM PUTS (PE).
These are PUTS which have only time value in them, no intrinsic value. CALLS however have both time value and intrinsic value in the premium.

Videos related to: Munafa ACAD (target) price & Options chain analysis (ACADIA Pharmaceuticals Inc.) Option chain analysis (ACAD) 18 Sun January Expiry

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Basics How To Trade In FnO Futures Options Stock Market

Munafa ACAD (target) price & Options chain analysis (ACADIA Pharmaceuticals Inc.) Option chain analysis (ACAD) 18 Sun January Expiry

 

Back to top